Epoetin alfa biosimilar (Opus Bio)

阿法依伯汀生物类似药 (Opus Bio)

Report date: 2022/12/26 14:43:50

Base Information

Drug NameEpoetin alfa biosimilar (Opus Bio)
Drug Alias NameHuman erythropoietin epoetin alfa (Opus Bio)阿法依伯汀生物仿制药 (Opus Bio)Recombinant Human Erythropoietin Alfa (Opus Bio)Hema-Plus
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOpus Bio
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpus Bio
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A